

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | endodermal cell differentiation (GO:0035987) | 4.57613414 |
| 2 | glomerular basement membrane development (GO:0032836) | 4.24152012 |
| 3 | chondrocyte proliferation (GO:0035988) | 4.14099128 |
| 4 | skin morphogenesis (GO:0043589) | 4.11501883 |
| 5 | protein heterotrimerization (GO:0070208) | 4.00437594 |
| 6 | type B pancreatic cell proliferation (GO:0044342) | 3.91640330 |
| 7 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.91411702 |
| 8 | glomerular visceral epithelial cell development (GO:0072015) | 3.88035046 |
| 9 | cell migration involved in heart development (GO:0060973) | 3.87825715 |
| 10 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.83936191 |
| 11 | substrate-dependent cell migration (GO:0006929) | 3.79655380 |
| 12 | cell-substrate junction assembly (GO:0007044) | 3.76181478 |
| 13 | actin filament depolymerization (GO:0030042) | 3.60409413 |
| 14 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.58422724 |
| 15 | glomerular epithelial cell development (GO:0072310) | 3.56856175 |
| 16 | extracellular matrix assembly (GO:0085029) | 3.49055145 |
| 17 | blood vessel maturation (GO:0001955) | 3.43742780 |
| 18 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.36082007 |
| 19 | wound healing, spreading of cells (GO:0044319) | 3.32807609 |
| 20 | extracellular fibril organization (GO:0043206) | 3.32801749 |
| 21 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.30903338 |
| 22 | substrate adhesion-dependent cell spreading (GO:0034446) | 3.28930712 |
| 23 | surfactant homeostasis (GO:0043129) | 3.28138276 |
| 24 | positive regulation of osteoblast proliferation (GO:0033690) | 3.27280860 |
| 25 | collagen metabolic process (GO:0032963) | 3.26611679 |
| 26 | chondrocyte development (GO:0002063) | 3.23055029 |
| 27 | metanephric tubule development (GO:0072170) | 3.22584024 |
| 28 | metanephric nephron tubule development (GO:0072234) | 3.22584024 |
| 29 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.22051987 |
| 30 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.20570952 |
| 31 | response to mercury ion (GO:0046689) | 3.17480266 |
| 32 | extracellular matrix disassembly (GO:0022617) | 3.17025917 |
| 33 | keratan sulfate catabolic process (GO:0042340) | 3.16898788 |
| 34 | metanephric nephron epithelium development (GO:0072243) | 3.12380837 |
| 35 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.10466020 |
| 36 | focal adhesion assembly (GO:0048041) | 3.08554768 |
| 37 | cell-substrate adherens junction assembly (GO:0007045) | 3.08554768 |
| 38 | negative regulation of fatty acid transport (GO:2000192) | 3.07662817 |
| 39 | metanephric epithelium development (GO:0072207) | 3.07502181 |
| 40 | collagen catabolic process (GO:0030574) | 3.06750447 |
| 41 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.05014890 |
| 42 | apoptotic cell clearance (GO:0043277) | 3.02153126 |
| 43 | adherens junction assembly (GO:0034333) | 3.01951466 |
| 44 | drug transmembrane transport (GO:0006855) | 3.00220466 |
| 45 | atrioventricular valve morphogenesis (GO:0003181) | 2.98564116 |
| 46 | lymph vessel development (GO:0001945) | 2.96452751 |
| 47 | positive regulation of fibroblast migration (GO:0010763) | 2.95951158 |
| 48 | Golgi transport vesicle coating (GO:0048200) | 2.94799989 |
| 49 | COPI coating of Golgi vesicle (GO:0048205) | 2.94799989 |
| 50 | multicellular organismal metabolic process (GO:0044236) | 2.92975039 |
| 51 | * extracellular matrix organization (GO:0030198) | 2.91896402 |
| 52 | * extracellular structure organization (GO:0043062) | 2.90715428 |
| 53 | smooth muscle tissue development (GO:0048745) | 2.90228059 |
| 54 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.89280037 |
| 55 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.88888174 |
| 56 | fibril organization (GO:0097435) | 2.88858579 |
| 57 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.87722976 |
| 58 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.86007010 |
| 59 | multicellular organismal catabolic process (GO:0044243) | 2.84024321 |
| 60 | protein retention in ER lumen (GO:0006621) | 2.83329597 |
| 61 | desmosome organization (GO:0002934) | 2.83321983 |
| 62 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.82097268 |
| 63 | lysine catabolic process (GO:0006554) | 2.81696273 |
| 64 | lysine metabolic process (GO:0006553) | 2.81696273 |
| 65 | sprouting angiogenesis (GO:0002040) | 2.81676881 |
| 66 | bone trabecula formation (GO:0060346) | 2.81571683 |
| 67 | endothelium development (GO:0003158) | 2.80533967 |
| 68 | negative regulation of cartilage development (GO:0061037) | 2.79066415 |
| 69 | positive regulation of endothelial cell migration (GO:0010595) | 2.78879575 |
| 70 | renal filtration (GO:0097205) | 2.78595097 |
| 71 | glomerulus development (GO:0032835) | 2.77367567 |
| 72 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.76139086 |
| 73 | positive regulation of extracellular matrix organization (GO:1903055) | 2.74969012 |
| 74 | barbed-end actin filament capping (GO:0051016) | 2.72695030 |
| 75 | cell adhesion mediated by integrin (GO:0033627) | 2.68443840 |
| 76 | regulation of chondrocyte differentiation (GO:0032330) | 2.68270914 |
| 77 | positive regulation of cartilage development (GO:0061036) | 2.67758894 |
| 78 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.66398280 |
| 79 | chemical homeostasis within a tissue (GO:0048875) | 2.65549831 |
| 80 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.65397034 |
| 81 | muscle cell migration (GO:0014812) | 2.64505310 |
| 82 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.63616234 |
| 83 | regulation of cartilage development (GO:0061035) | 2.63383267 |
| 84 | auditory receptor cell stereocilium organization (GO:0060088) | 2.63209583 |
| 85 | lymphangiogenesis (GO:0001946) | 2.63132812 |
| 86 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.62721627 |
| 87 | blood vessel remodeling (GO:0001974) | 2.61788706 |
| 88 | pericardium development (GO:0060039) | 2.61377880 |
| 89 | endocardial cushion development (GO:0003197) | 2.60802463 |
| 90 | hypotonic response (GO:0006971) | 2.60133957 |
| 91 | cellular response to vitamin (GO:0071295) | 2.58521603 |
| 92 | nephron tubule development (GO:0072080) | 2.57544575 |
| 93 | central nervous system myelination (GO:0022010) | 2.57209858 |
| 94 | axon ensheathment in central nervous system (GO:0032291) | 2.57209858 |
| 95 | endocrine hormone secretion (GO:0060986) | 2.56098274 |
| 96 | positive regulation of epithelial cell migration (GO:0010634) | 2.56009422 |
| 97 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.54675548 |
| 98 | cell-substrate adhesion (GO:0031589) | 2.53319495 |
| 99 | regulation of axon guidance (GO:1902667) | 2.53004744 |
| 100 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.51184350 |
| 101 | coronary vasculature morphogenesis (GO:0060977) | 2.49994266 |
| 102 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.48401179 |
| 103 | negative regulation of heart growth (GO:0061117) | 2.48401179 |
| 104 | positive regulation of receptor recycling (GO:0001921) | 2.48232284 |
| 105 | membrane raft organization (GO:0031579) | 2.47520941 |
| 106 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.46551906 |
| 107 | basement membrane organization (GO:0071711) | 2.45649233 |
| 108 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.42897886 |
| 109 | urate metabolic process (GO:0046415) | 2.40639519 |
| 110 | excretion (GO:0007588) | 2.40486428 |
| 111 | regulation of cardioblast differentiation (GO:0051890) | 2.40483853 |
| 112 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.39665776 |
| 113 | renal absorption (GO:0070293) | 2.37423656 |
| 114 | nephron epithelium development (GO:0072009) | 2.37326420 |
| 115 | phosphate ion transport (GO:0006817) | 2.37314963 |
| 116 | glyoxylate metabolic process (GO:0046487) | 2.35116658 |
| 117 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.35013431 |
| 118 | aspartate family amino acid catabolic process (GO:0009068) | 2.34990212 |
| 119 | renal tubule development (GO:0061326) | 2.33647546 |
| 120 | peripheral nervous system axon ensheathment (GO:0032292) | 2.32587429 |
| 121 | myelination in peripheral nervous system (GO:0022011) | 2.32587429 |
| 122 | short-chain fatty acid metabolic process (GO:0046459) | 2.32279543 |
| 123 | sodium-independent organic anion transport (GO:0043252) | 2.31507837 |
| 124 | drug catabolic process (GO:0042737) | 2.31141227 |
| 125 | glomerular filtration (GO:0003094) | 2.30094493 |
| 126 | myelin maintenance (GO:0043217) | 2.27217210 |
| 127 | venous blood vessel morphogenesis (GO:0048845) | 2.25048359 |
| 128 | negative regulation of axon guidance (GO:1902668) | 2.25034284 |
| 129 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.24773847 |
| 130 | L-phenylalanine catabolic process (GO:0006559) | 2.24773847 |
| 131 | exogenous drug catabolic process (GO:0042738) | 2.24182900 |
| 132 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.24011449 |
| 133 | phosphate ion transmembrane transport (GO:0035435) | 2.23013240 |
| 134 | plasma membrane repair (GO:0001778) | 2.22491629 |
| 135 | protein localization to endosome (GO:0036010) | 2.20082433 |
| 136 | creatine metabolic process (GO:0006600) | 2.19354740 |
| 137 | metanephric mesenchyme development (GO:0072075) | 2.18280649 |
| 138 | endothelial cell morphogenesis (GO:0001886) | 2.15988132 |
| 139 | drug transport (GO:0015893) | 2.15848262 |
| 140 | mesodermal cell differentiation (GO:0048333) | 2.14688704 |
| 141 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.13874821 |
| 142 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.10771911 |
| 143 | axon extension involved in axon guidance (GO:0048846) | 2.10771911 |
| 144 | adhesion of symbiont to host cell (GO:0044650) | 2.08565952 |
| 145 | virion attachment to host cell (GO:0019062) | 2.08565952 |
| 146 | regulation of p38MAPK cascade (GO:1900744) | 2.08496103 |
| 147 | cysteine metabolic process (GO:0006534) | 2.07498083 |
| 148 | epithelial cell-cell adhesion (GO:0090136) | 2.06808934 |
| 149 | positive regulation of p38MAPK cascade (GO:1900745) | 2.06110432 |
| 150 | kidney mesenchyme development (GO:0072074) | 2.05799331 |
| 151 | hemidesmosome assembly (GO:0031581) | 2.04052158 |
| 152 | regulation of glomerular filtration (GO:0003093) | 2.03846989 |
| 153 | collecting duct development (GO:0072044) | 2.03573876 |
| 154 | L-phenylalanine metabolic process (GO:0006558) | 2.03030614 |
| 155 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.03030614 |
| 156 | stress fiber assembly (GO:0043149) | 1.98460151 |
| 157 | wound healing, spreading of epidermal cells (GO:0035313) | 1.98387944 |
| 158 | regulation of cholesterol homeostasis (GO:2000188) | 1.97539256 |
| 159 | homocysteine metabolic process (GO:0050667) | 1.97023959 |
| 160 | regulation of plasminogen activation (GO:0010755) | 1.96006656 |
| 161 | epithelial cell differentiation involved in kidney development (GO:0035850) | 1.94844538 |
| 162 | renal tubule morphogenesis (GO:0061333) | 1.94751926 |
| 163 | negative regulation of protein localization to cell surface (GO:2000009) | 1.94437532 |
| 164 | renal system process involved in regulation of blood volume (GO:0001977) | 1.94369273 |
| 165 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 1.93599579 |
| 166 | quaternary ammonium group transport (GO:0015697) | 1.93569539 |
| 167 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 1.93325345 |
| 168 | semaphorin-plexin signaling pathway (GO:0071526) | 1.93323664 |
| 169 | camera-type eye morphogenesis (GO:0048593) | 1.93186027 |
| 170 | negative regulation of fibrinolysis (GO:0051918) | 1.93149147 |
| 171 | ganglion development (GO:0061548) | 1.91603045 |
| 172 | heart valve morphogenesis (GO:0003179) | 1.91437737 |
| 173 | lung vasculature development (GO:0060426) | 1.89800836 |
| 174 | collagen fibril organization (GO:0030199) | 1.89356118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.68476121 |
| 2 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.01308103 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.32825860 |
| 4 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.32303591 |
| 5 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.30961409 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.13623359 |
| 7 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.12468729 |
| 8 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.02758671 |
| 9 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.02575795 |
| 10 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.01541508 |
| 11 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.00456642 |
| 12 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.00456642 |
| 13 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.95848703 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.94470456 |
| 15 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.89077975 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.88937729 |
| 17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.85707142 |
| 18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.83804761 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.83354039 |
| 20 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.83221233 |
| 21 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.82806593 |
| 22 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.81080789 |
| 23 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.81080789 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.80580710 |
| 25 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.79576517 |
| 26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.79079974 |
| 27 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.77885876 |
| 28 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.75307552 |
| 29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.70017556 |
| 30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.66360711 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.65934345 |
| 32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.65454376 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.64494772 |
| 34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.63262728 |
| 35 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.60741059 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.60629445 |
| 37 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.58808497 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.57315271 |
| 39 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.53723379 |
| 40 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.53661490 |
| 41 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52680917 |
| 42 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.49476181 |
| 43 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.46112972 |
| 44 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.44752824 |
| 45 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.42097157 |
| 46 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.40021522 |
| 47 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.39828876 |
| 48 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.39047729 |
| 49 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.38775319 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.38483997 |
| 51 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38259663 |
| 52 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.36390316 |
| 53 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36144474 |
| 54 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34611951 |
| 55 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.32606825 |
| 56 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.32288159 |
| 57 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.31971196 |
| 58 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.31403723 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30833422 |
| 60 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.30439354 |
| 61 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.28941138 |
| 62 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.27267758 |
| 63 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.26880837 |
| 64 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26027519 |
| 65 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.25771216 |
| 66 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25751058 |
| 67 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.24516784 |
| 68 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.24213747 |
| 69 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.24213747 |
| 70 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.23908590 |
| 71 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.23699943 |
| 72 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.23071157 |
| 73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21463312 |
| 74 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20921247 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20711055 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.19374883 |
| 77 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.18864285 |
| 78 | TP53_16413492_ChIP-PET_HCT116_Human | 1.18564933 |
| 79 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.16372422 |
| 80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14986422 |
| 81 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14737564 |
| 82 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.14314990 |
| 83 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.14314990 |
| 84 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.14286293 |
| 85 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.13000834 |
| 86 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.12423918 |
| 87 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.11813512 |
| 88 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.10443938 |
| 89 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09654138 |
| 90 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.09436057 |
| 91 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.07383246 |
| 92 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.07314669 |
| 93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06140482 |
| 94 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05704324 |
| 95 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05075329 |
| 96 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.04562089 |
| 97 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.04220146 |
| 98 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03849452 |
| 99 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.03660225 |
| 100 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03282548 |
| 101 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03063040 |
| 102 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.02338685 |
| 103 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02158333 |
| 104 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02056476 |
| 105 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.01319413 |
| 106 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01181666 |
| 107 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.99901044 |
| 108 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99041261 |
| 109 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.98837683 |
| 110 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98484936 |
| 111 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.98067206 |
| 112 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.97217285 |
| 113 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.96915896 |
| 114 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96565700 |
| 115 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96448796 |
| 116 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.96393727 |
| 117 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.96340231 |
| 118 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.95647218 |
| 119 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94174255 |
| 120 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92434964 |
| 121 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.91359958 |
| 122 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.91091748 |
| 123 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.89411267 |
| 124 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.88613736 |
| 125 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88531082 |
| 126 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.88404563 |
| 127 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.87604166 |
| 128 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.87380430 |
| 129 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.86715095 |
| 130 | ATF3_27146783_Chip-Seq_COLON_Human | 0.86546577 |
| 131 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85901964 |
| 132 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85835023 |
| 133 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.85684658 |
| 134 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.85548849 |
| 135 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85002134 |
| 136 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.84952277 |
| 137 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84198620 |
| 138 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.82958361 |
| 139 | KDM2B_26808549_Chip-Seq_K562_Human | 0.82669800 |
| 140 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81842127 |
| 141 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.81725937 |
| 142 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.81333471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004272_abnormal_basement_membrane | 3.28242228 |
| 2 | MP0001958_emphysema | 2.96872841 |
| 3 | MP0005623_abnormal_meninges_morphology | 2.91164362 |
| 4 | MP0005257_abnormal_intraocular_pressure | 2.80143294 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 2.71704974 |
| 6 | MP0009384_cardiac_valve_regurgitation | 2.65324052 |
| 7 | MP0010368_abnormal_lymphatic_system | 2.57107792 |
| 8 | MP0005360_urolithiasis | 2.55282120 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.49564217 |
| 10 | MP0006054_spinal_hemorrhage | 2.33696827 |
| 11 | MP0004043_abnormal_pH_regulation | 2.31302276 |
| 12 | MP0005503_abnormal_tendon_morphology | 2.28758788 |
| 13 | MP0003195_calcinosis | 2.22178228 |
| 14 | MP0005275_abnormal_skin_tensile | 2.14443619 |
| 15 | MP0010030_abnormal_orbit_morphology | 2.00472296 |
| 16 | MP0000751_myopathy | 1.99377130 |
| 17 | MP0001542_abnormal_bone_strength | 1.98919391 |
| 18 | MP0005023_abnormal_wound_healing | 1.96328264 |
| 19 | MP0004885_abnormal_endolymph | 1.92036801 |
| 20 | MP0001879_abnormal_lymphatic_vessel | 1.91516042 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.82628481 |
| 22 | MP0005332_abnormal_amino_acid | 1.81677654 |
| 23 | MP0004084_abnormal_cardiac_muscle | 1.80987005 |
| 24 | MP0003252_abnormal_bile_duct | 1.70773640 |
| 25 | MP0002060_abnormal_skin_morphology | 1.65242408 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 1.62978155 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.60377652 |
| 28 | MP0010352_gastrointestinal_tract_polyps | 1.56579590 |
| 29 | MP0005167_abnormal_blood-brain_barrier | 1.55507752 |
| 30 | MP0003279_aneurysm | 1.53742516 |
| 31 | MP0002837_dystrophic_cardiac_calcinosis | 1.51810492 |
| 32 | MP0001756_abnormal_urination | 1.49530518 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.49233373 |
| 34 | MP0002295_abnormal_pulmonary_circulatio | 1.48991188 |
| 35 | MP0000537_abnormal_urethra_morphology | 1.43641454 |
| 36 | MP0002108_abnormal_muscle_morphology | 1.41218454 |
| 37 | MP0001765_abnormal_ion_homeostasis | 1.39353233 |
| 38 | MP0004036_abnormal_muscle_relaxation | 1.39343779 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 1.38218758 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.36363175 |
| 41 | MP0000534_abnormal_ureter_morphology | 1.31069287 |
| 42 | MP0006138_congestive_heart_failure | 1.30581261 |
| 43 | MP0005085_abnormal_gallbladder_physiolo | 1.28543924 |
| 44 | MP0002896_abnormal_bone_mineralization | 1.27622882 |
| 45 | MP0001348_abnormal_lacrimal_gland | 1.25510603 |
| 46 | MP0003950_abnormal_plasma_membrane | 1.25262417 |
| 47 | MP0004019_abnormal_vitamin_homeostasis | 1.24888159 |
| 48 | MP0000747_muscle_weakness | 1.24643972 |
| 49 | MP0003566_abnormal_cell_adhesion | 1.24570670 |
| 50 | MP0003045_fibrosis | 1.23072165 |
| 51 | MP0005365_abnormal_bile_salt | 1.22573107 |
| 52 | MP0000749_muscle_degeneration | 1.20448360 |
| 53 | MP0000920_abnormal_myelination | 1.20416379 |
| 54 | MP0002168_other_aberrant_phenotype | 1.19440431 |
| 55 | MP0004742_abnormal_vestibular_system | 1.19101914 |
| 56 | MP0000230_abnormal_systemic_arterial | 1.17046687 |
| 57 | MP0002136_abnormal_kidney_physiology | 1.15722640 |
| 58 | MP0005330_cardiomyopathy | 1.15471099 |
| 59 | MP0002972_abnormal_cardiac_muscle | 1.12434387 |
| 60 | MP0004484_altered_response_of | 1.11797002 |
| 61 | MP0000013_abnormal_adipose_tissue | 1.11031854 |
| 62 | MP0005620_abnormal_muscle_contractility | 1.10922280 |
| 63 | MP0003828_pulmonary_edema | 1.10285091 |
| 64 | MP0001243_abnormal_dermal_layer | 1.07068565 |
| 65 | MP0001299_abnormal_eye_distance/ | 1.06573934 |
| 66 | MP0005084_abnormal_gallbladder_morpholo | 1.05699299 |
| 67 | MP0003941_abnormal_skin_development | 1.03361853 |
| 68 | MP0003329_amyloid_beta_deposits | 1.03190433 |
| 69 | MP0004215_abnormal_myocardial_fiber | 1.01268256 |
| 70 | MP0005377_hearing/vestibular/ear_phenot | 1.00910236 |
| 71 | MP0003878_abnormal_ear_physiology | 1.00910236 |
| 72 | MP0000733_abnormal_muscle_development | 0.99917063 |
| 73 | MP0004233_abnormal_muscle_weight | 0.99530661 |
| 74 | MP0005595_abnormal_vascular_smooth | 0.99353489 |
| 75 | MP0005197_abnormal_uvea_morphology | 0.97101327 |
| 76 | MP0004858_abnormal_nervous_system | 0.96805207 |
| 77 | MP0005165_increased_susceptibility_to | 0.96569852 |
| 78 | MP0000767_abnormal_smooth_muscle | 0.96255958 |
| 79 | MP0003091_abnormal_cell_migration | 0.96148895 |
| 80 | MP0008775_abnormal_heart_ventricle | 0.96003398 |
| 81 | MP0002282_abnormal_trachea_morphology | 0.95851030 |
| 82 | MP0005164_abnormal_response_to | 0.95358518 |
| 83 | MP0000003_abnormal_adipose_tissue | 0.95291867 |
| 84 | MP0001915_intracranial_hemorrhage | 0.95179937 |
| 85 | MP0010386_abnormal_urinary_bladder | 0.95122648 |
| 86 | MP0003942_abnormal_urinary_system | 0.94577000 |
| 87 | MP0004087_abnormal_muscle_fiber | 0.94527933 |
| 88 | MP0004085_abnormal_heartbeat | 0.94208072 |
| 89 | MP0003283_abnormal_digestive_organ | 0.93105765 |
| 90 | MP0001661_extended_life_span | 0.93040526 |
| 91 | MP0001614_abnormal_blood_vessel | 0.92530023 |
| 92 | MP0000762_abnormal_tongue_morphology | 0.90531201 |
| 93 | MP0004145_abnormal_muscle_electrophysio | 0.89112137 |
| 94 | MP0003690_abnormal_glial_cell | 0.88607420 |
| 95 | MP0005390_skeleton_phenotype | 0.87290251 |
| 96 | MP0000759_abnormal_skeletal_muscle | 0.87088555 |
| 97 | MP0003191_abnormal_cellular_cholesterol | 0.86924851 |
| 98 | MP0004134_abnormal_chest_morphology | 0.85345822 |
| 99 | MP0009250_abnormal_appendicular_skeleto | 0.85260418 |
| 100 | MP0001849_ear_inflammation | 0.84961548 |
| 101 | MP0005409_darkened_coat_color | 0.83834938 |
| 102 | MP0003137_abnormal_impulse_conducting | 0.83525496 |
| 103 | MP0002796_impaired_skin_barrier | 0.83335302 |
| 104 | MP0005385_cardiovascular_system_phenoty | 0.83214187 |
| 105 | MP0001544_abnormal_cardiovascular_syste | 0.83214187 |
| 106 | MP0003300_gastrointestinal_ulcer | 0.83151099 |
| 107 | MP0000750_abnormal_muscle_regeneration | 0.82988246 |
| 108 | MP0000467_abnormal_esophagus_morphology | 0.81544472 |
| 109 | MP0002133_abnormal_respiratory_system | 0.80310038 |
| 110 | MP0005388_respiratory_system_phenotype | 0.80310038 |
| 111 | MP0005083_abnormal_biliary_tract | 0.80270241 |
| 112 | MP0005508_abnormal_skeleton_morphology | 0.78711067 |
| 113 | MP0002925_abnormal_cardiovascular_devel | 0.76581285 |
| 114 | MP0001177_atelectasis | 0.76090701 |
| 115 | MP0003385_abnormal_body_wall | 0.74998622 |
| 116 | MP0002128_abnormal_blood_circulation | 0.74579609 |
| 117 | MP0003634_abnormal_glial_cell | 0.74552064 |
| 118 | MP0000163_abnormal_cartilage_morphology | 0.73842281 |
| 119 | MP0005193_abnormal_anterior_eye | 0.73735671 |
| 120 | MP0003868_abnormal_feces_composition | 0.73363695 |
| 121 | MP0000462_abnormal_digestive_system | 0.73226354 |
| 122 | MP0002933_joint_inflammation | 0.72979098 |
| 123 | MP0003755_abnormal_palate_morphology | 0.72845407 |
| 124 | MP0002234_abnormal_pharynx_morphology | 0.71950554 |
| 125 | MP0002932_abnormal_joint_morphology | 0.71776403 |
| 126 | MP0005369_muscle_phenotype | 0.71732598 |
| 127 | MP0002115_abnormal_skeleton_extremities | 0.71247638 |
| 128 | MP0000579_abnormal_nail_morphology | 0.70981448 |
| 129 | MP0005666_abnormal_adipose_tissue | 0.70583277 |
| 130 | MP0000049_abnormal_middle_ear | 0.70271579 |
| 131 | MP0005670_abnormal_white_adipose | 0.69094392 |
| 132 | MP0005171_absent_coat_pigmentation | 0.68534414 |
| 133 | MP0003115_abnormal_respiratory_system | 0.68046434 |
| 134 | MP0000538_abnormal_urinary_bladder | 0.67791120 |
| 135 | MP0003448_altered_tumor_morphology | 0.67542287 |
| 136 | MP0009053_abnormal_anal_canal | 0.67485084 |
| 137 | MP0000428_abnormal_craniofacial_morphol | 0.66009422 |
| 138 | MP0002113_abnormal_skeleton_development | 0.65544552 |
| 139 | MP0000432_abnormal_head_morphology | 0.63590244 |
| 140 | MP0003935_abnormal_craniofacial_develop | 0.63311183 |
| 141 | MP0000249_abnormal_blood_vessel | 0.61389789 |
| 142 | MP0004782_abnormal_surfactant_physiolog | 0.60023029 |
| 143 | MP0001270_distended_abdomen | 0.59606666 |
| 144 | MP0001175_abnormal_lung_morphology | 0.57729845 |
| 145 | MP0004883_abnormal_blood_vessel | 0.55980765 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypokalemic alkalosis (HP:0001949) | 4.88910398 |
| 2 | Arterial tortuosity (HP:0005116) | 4.75745648 |
| 3 | Increased circulating renin level (HP:0000848) | 4.68278775 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 4.29802575 |
| 5 | Metabolic alkalosis (HP:0200114) | 4.24848461 |
| 6 | Soft skin (HP:0000977) | 4.22079565 |
| 7 | Abnormality of chloride homeostasis (HP:0011422) | 3.89363801 |
| 8 | Hypomagnesemia (HP:0002917) | 3.84437625 |
| 9 | Muscle fiber splitting (HP:0003555) | 3.77575043 |
| 10 | Fragile skin (HP:0001030) | 3.70366786 |
| 11 | Bladder diverticulum (HP:0000015) | 3.70050109 |
| 12 | Focal segmental glomerulosclerosis (HP:0000097) | 3.60075739 |
| 13 | Abnormality of dentin (HP:0010299) | 3.59607027 |
| 14 | Spondylolisthesis (HP:0003302) | 3.51770217 |
| 15 | Facial shape deformation (HP:0011334) | 3.45055947 |
| 16 | Potter facies (HP:0002009) | 3.45055947 |
| 17 | Gout (HP:0001997) | 3.41862336 |
| 18 | Mitral valve prolapse (HP:0001634) | 3.38165764 |
| 19 | Wormian bones (HP:0002645) | 3.37065947 |
| 20 | Ankle contracture (HP:0006466) | 3.34290461 |
| 21 | Abnormal urine output (HP:0012590) | 3.22171231 |
| 22 | Follicular hyperkeratosis (HP:0007502) | 3.20095170 |
| 23 | Polyuria (HP:0000103) | 3.17799756 |
| 24 | Hyperaldosteronism (HP:0000859) | 3.17269945 |
| 25 | Cervical subluxation (HP:0003308) | 3.16261408 |
| 26 | Dilatation of the ascending aorta (HP:0005111) | 3.16182801 |
| 27 | Glomerulosclerosis (HP:0000096) | 3.15104959 |
| 28 | Premature rupture of membranes (HP:0001788) | 3.13996189 |
| 29 | Blue sclerae (HP:0000592) | 3.12431590 |
| 30 | Renal salt wasting (HP:0000127) | 3.11318048 |
| 31 | Abnormality of renal excretion (HP:0011036) | 3.09216431 |
| 32 | Abnormality of magnesium homeostasis (HP:0004921) | 3.08280341 |
| 33 | Abnormality of renin-angiotensin system (HP:0000847) | 3.07462186 |
| 34 | Peritonitis (HP:0002586) | 3.05825483 |
| 35 | Aortic regurgitation (HP:0001659) | 3.03074099 |
| 36 | Tetany (HP:0001281) | 3.00206464 |
| 37 | Neonatal short-limb short stature (HP:0008921) | 3.00174258 |
| 38 | Genu recurvatum (HP:0002816) | 2.97718090 |
| 39 | Overgrowth (HP:0001548) | 2.86814334 |
| 40 | Cardiovascular calcification (HP:0011915) | 2.84425053 |
| 41 | Hypoplasia of the iris (HP:0007676) | 2.81930911 |
| 42 | Right ventricular cardiomyopathy (HP:0011663) | 2.79720137 |
| 43 | Abnormal drinking behavior (HP:0030082) | 2.77043610 |
| 44 | Polydipsia (HP:0001959) | 2.77043610 |
| 45 | Broad metatarsal (HP:0001783) | 2.74699100 |
| 46 | Joint laxity (HP:0001388) | 2.69360817 |
| 47 | Alkalosis (HP:0001948) | 2.68710049 |
| 48 | Hyporeflexia of lower limbs (HP:0002600) | 2.68575147 |
| 49 | Vascular calcification (HP:0004934) | 2.66605949 |
| 50 | Aneurysm (HP:0002617) | 2.59496673 |
| 51 | Hyperextensible skin (HP:0000974) | 2.58378832 |
| 52 | Mitral regurgitation (HP:0001653) | 2.54877521 |
| 53 | Aortic valve stenosis (HP:0001650) | 2.53134572 |
| 54 | Bowel diverticulosis (HP:0005222) | 2.47929325 |
| 55 | Hypokalemia (HP:0002900) | 2.47897579 |
| 56 | Abnormal delivery (HP:0001787) | 2.47881236 |
| 57 | Protrusio acetabuli (HP:0003179) | 2.43834428 |
| 58 | Deep venous thrombosis (HP:0002625) | 2.43438831 |
| 59 | Abnormality of the acetabulum (HP:0003170) | 2.43371389 |
| 60 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.42769372 |
| 61 | Mitral stenosis (HP:0001718) | 2.42360728 |
| 62 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.41615508 |
| 63 | Ectopia lentis (HP:0001083) | 2.38825519 |
| 64 | Vertebral compression fractures (HP:0002953) | 2.37697932 |
| 65 | Mesomelia (HP:0003027) | 2.36975657 |
| 66 | Osteolytic defects of the hand bones (HP:0009699) | 2.36740888 |
| 67 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.36740888 |
| 68 | Biconcave vertebral bodies (HP:0004586) | 2.35428500 |
| 69 | Wrist flexion contracture (HP:0001239) | 2.34657628 |
| 70 | Abnormality of potassium homeostasis (HP:0011042) | 2.33822810 |
| 71 | Neurofibrillary tangles (HP:0002185) | 2.33758635 |
| 72 | Shallow orbits (HP:0000586) | 2.32825451 |
| 73 | Wide anterior fontanel (HP:0000260) | 2.27982937 |
| 74 | Increased connective tissue (HP:0009025) | 2.26819401 |
| 75 | Short nail (HP:0001799) | 2.20669591 |
| 76 | Aplasia of the musculature (HP:0100854) | 2.19581744 |
| 77 | Tubulointerstitial fibrosis (HP:0005576) | 2.19179648 |
| 78 | Cerebral hemorrhage (HP:0001342) | 2.19113514 |
| 79 | Hydroxyprolinuria (HP:0003080) | 2.18680609 |
| 80 | Abnormality of proline metabolism (HP:0010907) | 2.18680609 |
| 81 | Aortic dissection (HP:0002647) | 2.18599919 |
| 82 | Hyperuricemia (HP:0002149) | 2.17071185 |
| 83 | Increased purine levels (HP:0004368) | 2.17071185 |
| 84 | Joint stiffness (HP:0001387) | 2.16370926 |
| 85 | Lymphangioma (HP:0100764) | 2.13829522 |
| 86 | Aortic aneurysm (HP:0004942) | 2.13093865 |
| 87 | Disproportionate tall stature (HP:0001519) | 2.11582810 |
| 88 | Ketoacidosis (HP:0001993) | 2.09094284 |
| 89 | Mesangial abnormality (HP:0001966) | 2.08821275 |
| 90 | Polycythemia (HP:0001901) | 2.08050209 |
| 91 | Slender build (HP:0001533) | 2.07712715 |
| 92 | Atrophic scars (HP:0001075) | 2.06855422 |
| 93 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.06323535 |
| 94 | Abnormality of the calf musculature (HP:0001430) | 2.03856342 |
| 95 | Elbow flexion contracture (HP:0002987) | 2.03314166 |
| 96 | Sudden death (HP:0001699) | 2.01598904 |
| 97 | Round ear (HP:0100830) | 2.01499585 |
| 98 | Difficulty running (HP:0009046) | 2.00229792 |
| 99 | Osteoarthritis (HP:0002758) | 1.99074493 |
| 100 | Ulnar bowing (HP:0003031) | 1.98754117 |
| 101 | Pulmonary artery stenosis (HP:0004415) | 1.98351812 |
| 102 | Chondrocalcinosis (HP:0000934) | 1.96931515 |
| 103 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.96063492 |
| 104 | Camptodactyly of toe (HP:0001836) | 1.95904407 |
| 105 | Distal lower limb muscle weakness (HP:0009053) | 1.94523980 |
| 106 | Stage 5 chronic kidney disease (HP:0003774) | 1.93980804 |
| 107 | Cerebral inclusion bodies (HP:0100314) | 1.93079097 |
| 108 | Hyperkalemia (HP:0002153) | 1.91557111 |
| 109 | Type 1 muscle fiber predominance (HP:0003803) | 1.91114608 |
| 110 | Gowers sign (HP:0003391) | 1.90721109 |
| 111 | Increased variability in muscle fiber diameter (HP:0003557) | 1.90135807 |
| 112 | Cerebral aneurysm (HP:0004944) | 1.89169668 |
| 113 | Striae distensae (HP:0001065) | 1.89078953 |
| 114 | Nonimmune hydrops fetalis (HP:0001790) | 1.87855607 |
| 115 | Broad ribs (HP:0000885) | 1.87719256 |
| 116 | Renal duplication (HP:0000075) | 1.87672066 |
| 117 | Vascular tortuosity (HP:0004948) | 1.87301995 |
| 118 | Visceral angiomatosis (HP:0100761) | 1.85958609 |
| 119 | Abnormality of Sharpey fibers (HP:0100685) | 1.85919449 |
| 120 | Aplasia involving bones of the extremities (HP:0009825) | 1.85629225 |
| 121 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.85629225 |
| 122 | Aplasia of the phalanges of the hand (HP:0009802) | 1.85629225 |
| 123 | Adrenal overactivity (HP:0002717) | 1.85549731 |
| 124 | Hypoplastic left heart (HP:0004383) | 1.83935209 |
| 125 | Spinal rigidity (HP:0003306) | 1.82708055 |
| 126 | Upper limb amyotrophy (HP:0009129) | 1.81958214 |
| 127 | Distal upper limb amyotrophy (HP:0007149) | 1.81958214 |
| 128 | Hypercalciuria (HP:0002150) | 1.80904055 |
| 129 | Xanthomatosis (HP:0000991) | 1.80679504 |
| 130 | Abnormality of purine metabolism (HP:0004352) | 1.80678606 |
| 131 | Inguinal hernia (HP:0000023) | 1.80596972 |
| 132 | Coxa vara (HP:0002812) | 1.80530467 |
| 133 | Abnormality of the anterior chamber (HP:0000593) | 1.79627365 |
| 134 | Nephritis (HP:0000123) | 1.79139892 |
| 135 | Coronal craniosynostosis (HP:0004440) | 1.78652395 |
| 136 | Broad face (HP:0000283) | 1.77984919 |
| 137 | Venous insufficiency (HP:0005293) | 1.76811615 |
| 138 | Generalized muscle weakness (HP:0003324) | 1.74794763 |
| 139 | Hip contracture (HP:0003273) | 1.74307177 |
| 140 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.74155616 |
| 141 | Short hallux (HP:0010109) | 1.74154588 |
| 142 | Thin bony cortex (HP:0002753) | 1.73691389 |
| 143 | Humeroradial synostosis (HP:0003041) | 1.71940922 |
| 144 | Synostosis involving the elbow (HP:0003938) | 1.71940922 |
| 145 | Knee flexion contracture (HP:0006380) | 1.71667839 |
| 146 | Ketosis (HP:0001946) | 1.71359593 |
| 147 | Natal tooth (HP:0000695) | 1.71336306 |
| 148 | Exercise-induced myalgia (HP:0003738) | 1.71111942 |
| 149 | Absent frontal sinuses (HP:0002688) | 1.70972653 |
| 150 | EMG: myopathic abnormalities (HP:0003458) | 1.70749636 |
| 151 | Abnormality of carpal bone ossification (HP:0006257) | 1.70252049 |
| 152 | Hypoplastic heart (HP:0001961) | 1.69581769 |
| 153 | Ovoid vertebral bodies (HP:0003300) | 1.69269492 |
| 154 | Scapular winging (HP:0003691) | 1.68456399 |
| 155 | Pulmonic stenosis (HP:0001642) | 1.68332220 |
| 156 | Infantile muscular hypotonia (HP:0008947) | 1.67865644 |
| 157 | Hypoventilation (HP:0002791) | 1.67520569 |
| 158 | Joint contractures involving the joints of the feet (HP:0100492) | 1.66678725 |
| 159 | Flexion contracture of toe (HP:0005830) | 1.66678725 |
| 160 | Flared iliac wings (HP:0002869) | 1.65984474 |
| 161 | Venous abnormality (HP:0002624) | 1.65716142 |
| 162 | Proximal tubulopathy (HP:0000114) | 1.65544040 |
| 163 | Flat cornea (HP:0007720) | 1.65465466 |
| 164 | Pterygium (HP:0001059) | 1.64891667 |
| 165 | Congenital glaucoma (HP:0001087) | 1.64638797 |
| 166 | Intrahepatic cholestasis (HP:0001406) | 1.64344241 |
| 167 | Redundant skin (HP:0001582) | 1.63640115 |
| 168 | Esophageal varix (HP:0002040) | 1.63163697 |
| 169 | Calf muscle hypertrophy (HP:0008981) | 1.63030032 |
| 170 | Limited hip movement (HP:0008800) | 1.62850051 |
| 171 | Thin skin (HP:0000963) | 1.62388482 |
| 172 | Abnormal ossification of hand bones (HP:0005921) | 1.62242514 |
| 173 | Distal lower limb amyotrophy (HP:0008944) | 1.61611814 |
| 174 | Hyperglycinuria (HP:0003108) | 1.60819167 |
| 175 | Premature skin wrinkling (HP:0100678) | 1.60584267 |
| 176 | Hemangiomatosis (HP:0007461) | 1.60408840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 4.59198143 |
| 2 | OXSR1 | 3.92725611 |
| 3 | STK39 | 3.32036293 |
| 4 | WNK3 | 3.24165767 |
| 5 | TIE1 | 3.09115676 |
| 6 | TESK1 | 2.65107803 |
| 7 | EPHA2 | 2.48261868 |
| 8 | NEK9 | 2.47430058 |
| 9 | EPHB2 | 2.28161866 |
| 10 | TGFBR2 | 2.05658997 |
| 11 | LATS2 | 2.00439630 |
| 12 | MYLK | 1.94590121 |
| 13 | TTN | 1.85160220 |
| 14 | LATS1 | 1.81883530 |
| 15 | EPHB1 | 1.78800352 |
| 16 | DDR2 | 1.74007771 |
| 17 | RIPK1 | 1.72988076 |
| 18 | TRIB3 | 1.67683499 |
| 19 | FER | 1.51727336 |
| 20 | PKN1 | 1.50415835 |
| 21 | PDGFRA | 1.43872880 |
| 22 | ERN1 | 1.43385241 |
| 23 | MST4 | 1.36671456 |
| 24 | PAK3 | 1.33044744 |
| 25 | SGK223 | 1.32900046 |
| 26 | SGK494 | 1.32900046 |
| 27 | MUSK | 1.32486926 |
| 28 | PTK6 | 1.31018809 |
| 29 | WNK1 | 1.30739095 |
| 30 | INSRR | 1.28752327 |
| 31 | MAP3K3 | 1.27902773 |
| 32 | PTK2 | 1.27121410 |
| 33 | NTRK1 | 1.21452017 |
| 34 | PIK3CA | 1.20140042 |
| 35 | MAP3K6 | 1.19352292 |
| 36 | CDC42BPA | 1.17672355 |
| 37 | FGFR4 | 1.16759900 |
| 38 | PRKG2 | 1.14824058 |
| 39 | PHKG1 | 1.13904525 |
| 40 | PHKG2 | 1.13904525 |
| 41 | PAK2 | 1.11440735 |
| 42 | MET | 1.11117743 |
| 43 | CAMK1G | 1.07937768 |
| 44 | SIK1 | 1.07007166 |
| 45 | PIK3CG | 1.04350044 |
| 46 | OBSCN | 1.03723028 |
| 47 | ROCK2 | 1.01021092 |
| 48 | DMPK | 0.97445728 |
| 49 | MST1R | 0.96062370 |
| 50 | GSK3A | 0.95430989 |
| 51 | PRKD1 | 0.94995703 |
| 52 | MAPK15 | 0.94647807 |
| 53 | DYRK1B | 0.94448410 |
| 54 | MAP3K12 | 0.94377790 |
| 55 | ROCK1 | 0.92576482 |
| 56 | AKT3 | 0.91441563 |
| 57 | RPS6KA2 | 0.90958556 |
| 58 | PTK2B | 0.90797770 |
| 59 | STK38L | 0.89402565 |
| 60 | MAPK7 | 0.86660342 |
| 61 | CSNK1A1L | 0.86395429 |
| 62 | ERBB4 | 0.85662461 |
| 63 | ICK | 0.85245319 |
| 64 | PDK2 | 0.84437558 |
| 65 | FLT3 | 0.83861767 |
| 66 | MTOR | 0.80688829 |
| 67 | PRKD3 | 0.80632618 |
| 68 | LRRK2 | 0.80002775 |
| 69 | FGFR2 | 0.79855591 |
| 70 | TRPM7 | 0.78499892 |
| 71 | MAP3K7 | 0.75375201 |
| 72 | STK24 | 0.74138071 |
| 73 | PAK4 | 0.73504714 |
| 74 | PDGFRB | 0.73303985 |
| 75 | PRKCH | 0.73037893 |
| 76 | PRKCE | 0.72869592 |
| 77 | CAMK2B | 0.72755516 |
| 78 | CAMK1D | 0.71892620 |
| 79 | SGK3 | 0.70966337 |
| 80 | ABL2 | 0.70573002 |
| 81 | KDR | 0.70303855 |
| 82 | LIMK1 | 0.69595582 |
| 83 | DAPK3 | 0.69486806 |
| 84 | LMTK2 | 0.68107159 |
| 85 | MAPKAPK3 | 0.66547985 |
| 86 | PAK6 | 0.66436764 |
| 87 | BCR | 0.65122063 |
| 88 | BCKDK | 0.64269478 |
| 89 | MAPK12 | 0.64203028 |
| 90 | STK3 | 0.63382096 |
| 91 | CSNK1G1 | 0.62723769 |
| 92 | PDK4 | 0.61502322 |
| 93 | PDK3 | 0.61502322 |
| 94 | PKN2 | 0.60951537 |
| 95 | CAMK2D | 0.60784742 |
| 96 | MARK1 | 0.60608125 |
| 97 | MAP2K1 | 0.60514606 |
| 98 | ILK | 0.59703347 |
| 99 | CAMK2G | 0.59350618 |
| 100 | CSNK1G3 | 0.59087962 |
| 101 | EPHA3 | 0.59012464 |
| 102 | CSNK1G2 | 0.58965179 |
| 103 | DAPK2 | 0.58772036 |
| 104 | MAP3K2 | 0.57770275 |
| 105 | MARK2 | 0.57123286 |
| 106 | PDPK1 | 0.55823302 |
| 107 | BMX | 0.55320783 |
| 108 | CAMK2A | 0.54932253 |
| 109 | SGK2 | 0.54917462 |
| 110 | MOS | 0.51656009 |
| 111 | RET | 0.51327662 |
| 112 | PRKD2 | 0.50864561 |
| 113 | TYRO3 | 0.50317026 |
| 114 | CDK8 | 0.50302372 |
| 115 | PRKAA2 | 0.49073248 |
| 116 | NTRK2 | 0.48826371 |
| 117 | GRK1 | 0.47062279 |
| 118 | SRC | 0.46756455 |
| 119 | MELK | 0.46726453 |
| 120 | TGFBR1 | 0.44563439 |
| 121 | STK38 | 0.43436413 |
| 122 | SCYL2 | 0.42634390 |
| 123 | CASK | 0.42319563 |
| 124 | ADRBK1 | 0.42261442 |
| 125 | INSR | 0.40246496 |
| 126 | MAP2K2 | 0.40146277 |
| 127 | JAK1 | 0.37565708 |
| 128 | KIT | 0.37358485 |
| 129 | GRK5 | 0.36910414 |
| 130 | CDK9 | 0.36234849 |
| 131 | ARAF | 0.35786092 |
| 132 | MAP2K3 | 0.35097774 |
| 133 | KSR2 | 0.33110645 |
| 134 | ZAP70 | 0.32494613 |
| 135 | IRAK3 | 0.31018632 |
| 136 | EEF2K | 0.31004600 |
| 137 | PIM2 | 0.28510005 |
| 138 | RPS6KC1 | 0.26721358 |
| 139 | RPS6KL1 | 0.26721358 |
| 140 | PAK1 | 0.25396220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.82260612 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.33014561 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.24280439 |
| 4 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.96757967 |
| 5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.95846359 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.93191242 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.91247264 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.87595555 |
| 9 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.86253818 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.76575841 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.75489388 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.62095906 |
| 13 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.61866765 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.60564218 |
| 15 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.56974884 |
| 16 | Bile secretion_Homo sapiens_hsa04976 | 1.52533406 |
| 17 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.51799556 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.44525159 |
| 19 | Focal adhesion_Homo sapiens_hsa04510 | 1.42191614 |
| 20 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.41694308 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.41557160 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.40331948 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.39544959 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.38920517 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.22543112 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.20347174 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.19206095 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.17402518 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13024383 |
| 30 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.12723820 |
| 31 | * Axon guidance_Homo sapiens_hsa04360 | 1.10285541 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.09359444 |
| 33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07978488 |
| 34 | Amoebiasis_Homo sapiens_hsa05146 | 1.07757323 |
| 35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.06595676 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06575618 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.06477915 |
| 38 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.06226891 |
| 39 | Melanoma_Homo sapiens_hsa05218 | 1.05542323 |
| 40 | Pathways in cancer_Homo sapiens_hsa05200 | 1.04456513 |
| 41 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.04413043 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04023059 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02938203 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.02006419 |
| 45 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.01432244 |
| 46 | Prion diseases_Homo sapiens_hsa05020 | 1.01376263 |
| 47 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.01229462 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.99257052 |
| 49 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.98768023 |
| 50 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.97626371 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 0.94087661 |
| 52 | Tight junction_Homo sapiens_hsa04530 | 0.93434071 |
| 53 | Mineral absorption_Homo sapiens_hsa04978 | 0.92655551 |
| 54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.90715231 |
| 55 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.89972320 |
| 56 | Malaria_Homo sapiens_hsa05144 | 0.88906634 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.87105953 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.84022645 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83768825 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83171942 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82584032 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82502824 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81150904 |
| 64 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.80405459 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79722663 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79492244 |
| 67 | Renin secretion_Homo sapiens_hsa04924 | 0.79332050 |
| 68 | Glioma_Homo sapiens_hsa05214 | 0.79230807 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79149384 |
| 70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78422153 |
| 71 | Retinol metabolism_Homo sapiens_hsa00830 | 0.77869302 |
| 72 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76711702 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.76570974 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75509920 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.73986786 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73063803 |
| 77 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.71936335 |
| 78 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.69608502 |
| 79 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.69349998 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69187390 |
| 81 | Adherens junction_Homo sapiens_hsa04520 | 0.68753000 |
| 82 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.67971132 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67083915 |
| 84 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66350798 |
| 85 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65581015 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.64710363 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.63078702 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62908968 |
| 89 | Salivary secretion_Homo sapiens_hsa04970 | 0.62040851 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61266183 |
| 91 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.60923757 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60757012 |
| 93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59854792 |
| 94 | Shigellosis_Homo sapiens_hsa05131 | 0.59549286 |
| 95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59477650 |
| 96 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.59171062 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58841083 |
| 98 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58774103 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58137251 |
| 100 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57853370 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.57712824 |
| 102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57597620 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56676904 |
| 104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54901901 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54852293 |
| 106 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.54804390 |
| 107 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54407958 |
| 108 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54176443 |
| 109 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53830512 |
| 110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53670697 |
| 111 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53634835 |
| 112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53595993 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | 0.53517495 |
| 114 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52888493 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52233980 |
| 116 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52201620 |
| 117 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51903628 |
| 118 | ABC transporters_Homo sapiens_hsa02010 | 0.51029426 |
| 119 | Other glycan degradation_Homo sapiens_hsa00511 | 0.50849713 |
| 120 | Pertussis_Homo sapiens_hsa05133 | 0.49873262 |
| 121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.49845736 |
| 122 | Gap junction_Homo sapiens_hsa04540 | 0.49424032 |
| 123 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.49197897 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.49088748 |
| 125 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.48147932 |
| 126 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48097259 |
| 127 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47987683 |
| 128 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.47750898 |
| 129 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.47558846 |
| 130 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47167018 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46680947 |
| 132 | GABAergic synapse_Homo sapiens_hsa04727 | 0.45784525 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44953800 |
| 134 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44667093 |
| 135 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44405784 |
| 136 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43032954 |
| 137 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43000977 |
| 138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42143284 |
| 139 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41269512 |
| 140 | Taste transduction_Homo sapiens_hsa04742 | 0.41259105 |
| 141 | Cocaine addiction_Homo sapiens_hsa05030 | 0.41235259 |
| 142 | Insulin resistance_Homo sapiens_hsa04931 | 0.41223935 |
| 143 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41091819 |
| 144 | Salmonella infection_Homo sapiens_hsa05132 | 0.40544606 |
| 145 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.40370268 |
| 146 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.40262466 |
| 147 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.40196877 |
| 148 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39266307 |
| 149 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.38708918 |
| 150 | Lysosome_Homo sapiens_hsa04142 | 0.38353387 |
| 151 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35956976 |
| 152 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35748452 |
| 153 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35553368 |
| 154 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34234818 |
| 155 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32606429 |

